ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 249

Medial Subchondral Bone Marrow Lesions Increase the Odds of Knee Joint Replacement – Data From the Osteoarthritis Initative

Frank Roemer1, C. Kent Kwoh2, David Hunter3, Michael J. Hannon4, Robert M. Boudreau5, Felix Eckstein6, Zhijie Wang4, Markus R. John7 and Ali Guermazi8, 1Klinikum Augsburg, Augsburg, Germany, 2School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 3Royal North Shore Hospital, St. Leonards, Australia, 4Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Epidemiology, University of Pittsburgh, Pittsburgh, PA, 6Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, 7Novartis Pharma AG, Basel, Switzerland, 8Boston University, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), osteoarthritis and total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Knee joint replacement (KR) is a cost-effective procedure with good long-term outcomes. However, there is no clear consensus on indications for KR. Subchondral bone marrow lesions (BMLs) have been identified as important structural features relevant to clinical manifestation (e.g.pain) as well as structural progression (e.g. cartilage loss). Thus, BMLs are promising biomarkers for structural progression to important clinical outcomes such as KR. The aims of this study were therefore to test whether presence and size of BMLs increased odds of KR, and whether worsening of BMLs over time increased odds of KR.

Methods: We studied 121 knees from OAI participants that underwent KR before the 48 month visit at two time points (T0 and T-1) prior to KR, (i.e. for a KR reported at the 48 month (M) visit, T0 = 36M and T-1 = 24M). These were matched with 121 control knees that did not undergo KR based on radiographic disease stage, sex, and age (+/- 5y). 3Tesla MRIs were read for subchondral BMLs in 14 articular subregions using the semiquantitative MOAKS system. Only BML size, which is scored from 0-3, was considered in this study. Analyses were performed on a plate (medial tibia, medial femur, lateral tibia, lateral femur, trochlea, patella) and compartmental level (medial tibio-femoral joint [TFJ], lateral TFJ and patello-femoral joint – [PFJ]). Conditional logistic regression was applied to assess the risk of KR relative to the maximum BML size per plate at T0. In addition, the number of subregions per compartment showing BML worsening from the time point prior T0 (=T-1) to T0 was analyzed relative to the odds of KR following T0.

Results: Subjects were on average 65.3 years old (SD ± 8.6), predominantly female (58.1%) and overweight (mean BMI 29.6 SD ± 4.9). The odds of KR were significantly greater for knees exhibiting large (i.e. grade 3) BMLs in the medial compartment when compared to the knees without BMLs at T0 (Table 1). Further, the odds for KR were significantly greater for knees with ≥3 subregions exhibiting increase in BML size in the medial TF compartment from T-1 to T0 compared to knees with no subregions showing worsening (OR 3.35, 95%CI 1.14-9.82). No significant associations were found for smaller lesions, the lateral TFJ and PFJ and respective plates cross-sectionally or longitudinally.

Conclusion: On a plate-level analysis, presence of large BMLs in the medial femur and/or tibia at the time point prior to KR was associated with increased odds of KR, while presence of large BMLs in the lateral TFJ or in the PFJ was not. Worsening of BML size in ≥3 subregions in the medial TF compartment from T-1 to T0 was associated with increased odds of KR when compared to knees without worsening in any subregion in the same compartment.

 


Disclosure:

F. Roemer,

Boston Imaging Core Lab,

1,

National Institute of Health,

5,

Merck Serono,

5;

C. K. Kwoh,

Novartis Pharmaceutical Corporation,

5;

D. Hunter,

Australia Research Council Future Fellowship,

2,

DonJoy,

5,

NIH,

5,

Stryker,

5;

M. J. Hannon,
None;

R. M. Boudreau,
None;

F. Eckstein,

Chondrometrics GmbH,

3,

Chondrometrics GmbH,

4,

Novartis AG,

2,

Novartis, MerckSeronoSanofi Aventis, Abbot, Perceptive, Bioclinica,

5;

Z. Wang,
None;

M. R. John,

Novartis Pharma AG,

1,

Novartis Pharma AG,

3;

A. Guermazi,

Boston Imaging Core Lab,

1,

Stryker,

5,

Merck Serono,

5,

Genzyme Corporation,

5,

AstraZeneca,

5,

Novartis Pharmaceutical Corporation,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/medial-subchondral-bone-marrow-lesions-increase-the-odds-of-knee-joint-replacement-data-from-the-osteoarthritis-initative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology